Loading...
•
Sep 30, 2021
Nuwellis Q3 2021 Earnings Report
Nuwellis's revenue declined slightly due to COVID-19 headwinds but gross margin improved due to favorable product mix.
Key Takeaways
Nuwellis reported a slight decrease in revenue for Q3 2021 compared to the prior year, driven by COVID-19 impacts. However, gross margin increased due to favorable product mix, and the company opened new pediatric accounts. The company completed a capital raise of $10 million and ended the quarter with $28.4 million in cash.
Total revenue was $1.9 million, a 3% decrease compared to the prior-year period.
Gross margin increased to 60.4% compared to 46.1% in the prior year period due to favorable geographic and product mix.
Opened three new pediatric accounts, marking the largest quarterly addition in 2021.
Completed a $10.0 million all-common stock capital raise, ending the quarter with $28.4 million in cash and no debt.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...